Clinical trials recruiting for Metastatic Hormone Sensitive Prostate Cancer
8
Recruiting trials
15
US states with sites
14
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 2 |
| Ohio | 2 |
| Alabama | 1 |
| California | 1 |
| Illinois | 1 |
| Louisiana | 1 |
| Michigan | 1 |
| Missouri | 1 |
| New Mexico | 1 |
| New York | 1 |
| Pennsylvania | 1 |
| South Carolina | 1 |
Top cities
Albuquerque, New Mexico 1Brooklyn, New York 1Charlottesville, Virginia 1Chicago Ridge, Illinois 1Cincinnati, Ohio 1Cleveland, Ohio 1Evanston, Illinois 1Grand Rapids, Michigan 1Huntsville, Alabama 1Madison, Wisconsin 1
Self-screener
Recruiting trials
- A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
- A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France
- A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer
- A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics
- An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
- Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.
- Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).
Related conditions
Trials recruiting for Metastatic Hormone Sensitive Prostate Cancer often also study these conditions. Each links to its own recruiting-trial list.
Prostate cancer 1234Metastatic Castration-Resistant Prostate Cancer 67Prostatic Neoplasms 36Non-metastatic Castration-resistant Prostate Cancer 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic Hormone Sensitive Prostate Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.